Jane De Lartigue, PhD

Article

Emerging biosimilars market presents opportunities and challenges

Author:: Jane De Lartigue, PhD

Read More

Article

Paradigm-changing osimertinib approval in front-line for advanced NSCLC

Author:: Jane De Lartigue, PhD

Read More

Article

BRAF-MEK inhibitor combo approved for adjuvant melanoma therapy

Author:: Jane De Lartigue, PhD

Read More

Article

Immunotherapy may hold the key to defeating virally associated cancers

Author:: Jane De Lartigue, PhD

Read More

Article

Game changers in pediatric cancer

Author:: Jane De Lartigue, PhD

Read More

Article

Addressing the rarity and complexities of sarcomas

Author:: Jane De Lartigue, PhD

Read More

Article

Tumor heterogeneity: a central foe in the war on cancer

Author:: Jane De Lartigue, PhD

Read More

Article

Expanding treatment options for diverse neuroendocrine tumors

Author:: Jane De Lartigue, PhD

Read More

Article

Hallmark tumor metabolism becomes a validated therapeutic target

Author:: Jane De Lartigue, PhD

Read More

Article

Targeted therapies forge ahead in multiple breast cancer subtypes

Author:: Jane De Lartigue, PhD

Read More

Article

Pancreatic cancer: a therapeutic challenge yet to be met

Author:: Jane De Lartigue, PhD

Read More

Article

Slow and steady progress in managing gynecologic cancer

Author:: Jane De Lartigue, PhD

Read More